Skip to main content
EVGN
NASDAQ Industrial Applications And Services

Evogene Establishes Highly Dilutive $2.9M ATM Offering Amidst Delisting Concerns

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.598
Mkt Cap
$7.238M
52W Low
$0.521
52W High
$2.03
52W Position info
15% above low
Off High info
71% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

EVGN is trading near its 52-week low of $0.521 (15% above the low) on light trading volume (0.3× avg).

Summary

Evogene Ltd. launched a new At-The-Market (ATM) offering to sell up to $2.9 million in shares, representing over 40% of its market cap, as it navigates delisting threats and going concern doubts.


Key Events · Financing and Capital Events · EVGN

  • New ATM Program Established

    Evogene entered into a Sales Agreement with A.G.P./Alliance Global Partners to sell up to $2,926,500 of ordinary shares through an At-The-Market (ATM) offering.

  • Significant Potential Dilution

    The maximum offering amount of $2.9 million represents over 40% of the company's current market capitalization, indicating a highly dilutive capital raise if fully utilized.

  • Context of Financial Distress

    This capital raise follows recent disclosures of a Nasdaq delisting notice, substantial doubt about the company's ability to continue as a going concern, and a wider net loss in Q1 2026.

  • Utilizes Existing Shelf Registration

    The shares will be issued under a shelf registration statement on Form F-3 (File No. 333-277565) that was declared effective on March 28, 2024.


Analysis · EVGN · Industrial Applications And Services

Evogene Ltd. has established an At-The-Market (ATM) offering program to sell up to $2.9 million in ordinary shares. This represents over 40% of the company's current market capitalization, indicating a highly dilutive capital raise. The company is currently facing a Nasdaq delisting notice and has previously disclosed substantial doubt about its ability to continue as a going concern, making this capital raise critical for its operational runway but at a significant cost to existing shareholders.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EVGN was trading at $0.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.2M. The 52-week trading range was $0.52 to $2.03. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Nov 19, 2026, 7:12 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.3233
Real-time Price: $0.313 info
Change: -$0.0103 (-3%) info
Market Cap: $5.708M info
EVGN
Nov 16, 2026, 7:01 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3646
Real-time Price: $0.313 info
Change: -$0.0516 (-14%) info
Market Cap: $5.708M info
EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.313 info
Change: -$0.0971 (-24%) info
Market Cap: $5.708M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.313 info
Change: -$0.1038 (-25%) info
Market Cap: $5.708M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.313 info
Change: -$0.0777 (-20%) info
Market Cap: $5.708M info